A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia. uri icon

authors

  • Wu, Jie
  • Kwan, Angela Th
  • T. Greg Rhee, PhD
  • Ho, Roger
  • d'Andrea, Giacomo
  • Martinotti, Giovanni
  • Teopiz, Kayla M
  • Ceban, Felicia
  • McIntyre, Roger S

publication date

  • November 22, 2023